Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Sunitinib. Show all posts
Showing posts with label Sunitinib. Show all posts
Tuesday, May 12, 2015

Sorafenib, sunitinib provide no benefit to patients with locally advanced kidney cancer

›
Findings from a federally funded study suggest that patients with locally advanced kidney cancer should not be treated with either adjuvan...
Tuesday, December 20, 2011

Drug Duo of Ixabepilone and sunitinib Kills Chemotherapy-resistant Ovarian Cancer Cells......

›
In continuation of Sunitinib ... The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent des...
Thursday, May 5, 2011

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors....

›
In continuation of my update on sutent/sunitib ....  Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor ...
Monday, February 22, 2010

Researchers able to predict and reverse resistance to Sunitinib treatment....

›
Van Andel Research Institute (VARI) researchers have found a way to  reverse resistance to Sunitinib ( see structure) , a treatment t...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.